from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: WINDTREE THERAPEUTICS INC /DE/ quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2012 to 30 Sep 2025.
WINDTREE THERAPEUTICS INC /DE/ Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 26,675,559, a 150270% increase year-over-year.
WINDTREE THERAPEUTICS INC /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 52,583,000, a 1123% increase from 2023.
WINDTREE THERAPEUTICS INC /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4,300,000, a 583% increase from 2022.
WINDTREE THERAPEUTICS INC /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 630,000, a 27% increase from 2021.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	26,675,559	+26,657,819	+150270%	01 Jul 2025	30 Sep 2025	10-Q	19 Nov 2025	2025	Q3
Q2 2025	4,877,257	+4,865,760		01 Apr 2025	30 Jun 2025	10-Q	19 Aug 2025	2025	Q2
Q1 2025	1,088,564,000	+1,079,269,000	+11611%	01 Jan 2025	31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q4 2024	52,583,000	+48,283,000	+1123%	01 Oct 2024	31 Dec 2024	10-K	15 Apr 2025	2024	FY
Q3 2024	17,740	-268,260	-94%	01 Jul 2024	30 Sep 2024	10-Q	19 Nov 2025	2025	Q3
Q2 2024	11,497^*	-212,503		01 Apr 2024	30 Jun 2024	10-Q	19 Aug 2025	2025	Q2
Q1 2024	9,295,000	+9,247,000	+19265%	01 Jan 2024	31 Mar 2024	10-Q	15 May 2025	2025	Q1
Q4 2023	4,300,000	+3,670,000	+583%	01 Oct 2023	31 Dec 2023	10-K	15 Apr 2025	2024	FY
Q3 2023	286,000	-337,000	-54%	01 Jul 2023	30 Sep 2023	10-Q	26 Nov 2024	2024	Q3
Q2 2023	224,000	-360,000	-62%	01 Apr 2023	30 Jun 2023	10-Q	19 Aug 2024	2024	Q2
Q1 2023	48,000	-518,000	-92%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2024	2024	Q1
Q4 2022	630,000	+135,000	+27%	01 Oct 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q3 2022	623,000	-26,081,000	-98%	01 Jul 2022	30 Sep 2022	10-Q	09 Nov 2023	2023	Q3
Q2 2022	584,000	-25,766,000	-98%	01 Apr 2022	30 Jun 2022	10-Q	07 Aug 2023	2023	Q2
Q1 2022	566,000	-17,129,000	-97%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q4 2021	495,000			01 Oct 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021	26,704,000			01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2022	Q3
Q2 2021	26,350,000			01 Apr 2021	30 Jun 2021	10-Q	11 Aug 2022	2022	Q2
Q1 2021	17,695,000			01 Jan 2021	31 Mar 2021	10-Q	05 May 2022	2022	Q1
Q4 2018	7,191,000	+4,786,000	+199%	01 Oct 2018	31 Dec 2018	10-K/A	23 Apr 2019	2018	FY
Q3 2018	3,769,000	+3,040,000	+417%	01 Jul 2018	30 Sep 2018	10-K/A	23 Apr 2019	2018	FY
Q2 2018	3,751,000	+3,244,000	+640%	01 Apr 2018	30 Jun 2018	10-K/A	23 Apr 2019	2018	FY
Q1 2018	3,227,000	+2,777,000	+617%	01 Jan 2018	31 Mar 2018	10-K/A	23 Apr 2019	2018	FY
Q4 2017	2,405,000	-6,118,000	-72%	01 Oct 2017	31 Dec 2017	10-K/A	23 Apr 2019	2018	FY
Q3 2017	729,000	-7,626,000	-91%	01 Jul 2017	30 Sep 2017	10-K/A	23 Apr 2019	2018	FY
Q2 2017	507,000	-7,731,000	-94%	01 Apr 2017	30 Jun 2017	10-K/A	23 Apr 2019	2018	FY
Q1 2017	450,000	-7,741,000	-95%	01 Jan 2017	31 Mar 2017	10-K/A	23 Apr 2019	2018	FY
Q4 2016	8,523,000	+473,000	+5.9%	01 Oct 2016	31 Dec 2016	10-K	31 Mar 2017	2016	FY
Q3 2016	8,355,000	+805,000	+11%	01 Jul 2016	30 Sep 2016	10-K	31 Mar 2017	2016	FY
Q2 2016	8,238,000	+2,113,000	+34%	01 Apr 2016	30 Jun 2016	10-K	31 Mar 2017	2016	FY
Q1 2016	8,191,000	+2,077,000	+34%	01 Jan 2016	31 Mar 2016	10-K	31 Mar 2017	2016	FY
Q4 2015	8,050,000	+1,953,000	+32%	01 Oct 2015	31 Dec 2015	10-K	31 Mar 2017	2016	FY
Q3 2015	7,550,000	+1,464,000	+24%	01 Jul 2015	30 Sep 2015	10-K	31 Mar 2017	2016	FY
Q2 2015	6,125,000	+49,000	+0.81%	01 Apr 2015	30 Jun 2015	10-K	31 Mar 2017	2016	FY
Q1 2015	6,114,000	+62,000	+1%	01 Jan 2015	31 Mar 2015	10-K	31 Mar 2017	2016	FY
Q4 2014	6,097,000	-67,032,000	-92%	01 Oct 2014	31 Dec 2014	10-K	29 Mar 2016	2015	FY
Q3 2014	6,086,000	-48,706,000	-89%	01 Jul 2014	30 Sep 2014	10-K	29 Mar 2016	2015	FY
Q2 2014	6,076,000	-43,059,000	-88%	01 Apr 2014	30 Jun 2014	10-K	29 Mar 2016	2015	FY
Q1 2014	6,052,000	-37,605,000	-86%	01 Jan 2014	31 Mar 2014	10-K	29 Mar 2016	2015	FY
Q4 2013	73,129,000			01 Oct 2013	31 Dec 2013	10-K	16 Mar 2015	2014	FY
Q3 2013	54,792,000	+11,348,000	+26%	01 Jul 2013	30 Sep 2013	10-K	16 Mar 2015	2014	FY
Q2 2013	49,135,000	+5,766,000	+13%	01 Apr 2013	30 Jun 2013	10-K	16 Mar 2015	2014	FY
Q1 2013	43,657,000			01 Jan 2013	31 Mar 2013	10-K	16 Mar 2015	2014	FY
Q3 2012	43,444,000			01 Jul 2012	30 Sep 2012	10-Q	12 Nov 2013	2013	Q3
Q2 2012	43,369,000			01 Apr 2012	30 Jun 2012	10-Q	08 Aug 2013	2013	Q2

WINDTREE THERAPEUTICS INC /DE/ Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	52,583,000	+48,283,000	+1123%	01 Jan 2024	31 Dec 2024	10-K	15 Apr 2025	2024	FY
2023	4,300,000	+3,670,000	+583%	01 Jan 2023	31 Dec 2023	10-K	15 Apr 2025	2024	FY
2022	630,000	+135,000	+27%	01 Jan 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
2021	495,000			01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
2018	4,493,000	+3,465,000	+337%	01 Jan 2018	31 Dec 2018	10-K/A	23 Apr 2019	2018	FY
2017	1,028,000	-7,300,000	-88%	01 Jan 2017	31 Dec 2017	10-K/A	23 Apr 2019	2018	FY
2016	8,328,000	+1,361,000	+20%	01 Jan 2016	31 Dec 2016	10-K	31 Mar 2017	2016	FY
2015	6,967,000	+889,000	+15%	01 Jan 2015	31 Dec 2015	10-K	31 Mar 2017	2016	FY
2014	6,078,000	-49,180,000	-89%	01 Jan 2014	31 Dec 2014	10-K	29 Mar 2016	2015	FY
2013	55,258,000	+15,862,000	+40%	01 Jan 2013	31 Dec 2013	10-K	16 Mar 2015	2014	FY
2012	39,396,000			01 Jan 2012	31 Dec 2012	10-K	16 Mar 2015	2014	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.